You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 139 No. 3, March 1979 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on Web of Science (47)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Benign Mass Lesions After Therapy for Hodgkin's Disease

Walter Durkin, MD; John Durant, MD

Arch Intern Med. 1979;139(3):333-336.


Abstract

Two patients with stage 2A Hodgkin's disease were treated with chemotherapy followed by radiation therapy. After treatment, both patients had mass lesions. Resection and histologic examination of these lesions showed only fibrosis, necrosis, and inflammation. Benign mass lesions occurring after therapy for Hodgkin's disease have not been previously described.

(Arch Intern Med 139:333-336, 1979)



Author Affiliations

From the Department of Medicine and Comprehensive Cancer Center, University of Alabama, Birmingham.


Footnotes

Accepted for publication Nov 10, 1978.

Reprint requests to Comprehensive Cancer Center, Birmingham, AL 35294 (Dr Durant).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1979 American Medical Association. All Rights Reserved.